Biotechnology
7 companies under coverage.
Biotechnology
Incyte Corporation (INCY)
The bull case — 'Bull — Blockbuster / Pipeline Re-Rate' (8% weight) — targets $193, +70% vs spot. It needs the multiple to hold or expand.
Regeneron Pharmaceuticals Inc (REGN)
The bull case — 'Bull — Blockbuster / Pipeline Re-Rate' (8% weight) — targets $1,106, +77% vs spot. It needs the multiple to hold or expand.
Gilead Sciences Inc (GILD)
The bull case — 'Bull — Blockbuster / Pipeline Re-Rate' (8% weight) — targets $216, +71% vs spot. It needs the multiple to hold or expand.
Biogen Inc (BIIB)
The bull case — 'Bull — Blockbuster / Pipeline Re-Rate' (8% weight) — targets $346, +60% vs spot. It needs the multiple to hold or expand.
Amgen Inc (AMGN)
The bull case — 'Bull — Blockbuster / Pipeline Re-Rate' (8% weight) — targets $630, +74% vs spot. It needs the multiple to hold or expand.
Vertex Pharmaceuticals Inc (VRTX)
The bull case — 'Bull — Blockbuster / Pipeline Re-Rate' (8% weight) — targets $841, +69% vs spot. It needs the multiple to hold or expand.
AbbVie Inc (ABBV)
The bull case — 'Bull — Blockbuster / Pipeline Re-Rate' (8% weight) — targets $418, +66% vs spot. It needs the multiple to hold or expand.